Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2003;327:923 (18 October), doi:10.1136/bmj.327.7420.923
| The first 150 words of the full text of this article appear below. |
An elderly Serbian woman recently presented to the hospice with symptoms of persistent nausea. She had developed breast cancer in 1980 and had undergone a mastectomy. Her disease had relapsed in 1993 and 1997. She had a history of hypothyroidism and asthma. She had been taking regular inhalers, thyroxine, and slow release aminophylline for many years.
In December 2002 she was admitted to a London teaching hospital with nausea and vomiting; trial treatment with cyclizine, levomepromazine, and metoclopramide met with limited success. Her thyroid function tests were normal, as were her renal function, liver function, and bone profile. A brain scan had ruled out brain metastases; an abdominal ultrasound ruled out liver metastases.
She was discharged from hospital in mid-January, but her symptoms had not improved. She was admitted to the hospice two weeks later. Again, we tried various combinations of antiemetics by subcutaneous infusion, we treated her constipation, and
Rosemarie Anthony-Pillai, registrar in palliative care
Pembridge Palliative Care Unit, St Charles Hospital, London
What can you learn from this BMJ paper? Read Leanne Tite's Paper+